4 Breakout Biotech Stocks Under $10 to Watch

DELAFIELD, Wis. (Stockpickr) -- As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Catalyst Pharmaceuticals

Catalyst Pharmaceuticals  (CPRX), a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting rare (orphan) neurological diseases and disorders. This stock is trading up 5% to $4.12 share in Thursday's trading session.

Thursday's Range: $3.94-$4.13
52-Week Range: $2.13-$5.10
Thursday's Volume: 597,000
Three-Month Average Volume: 837,273

From a technical perspective, Catalyst Pharmaceuticals is ripping sharply higher here right off its 50-day moving average of $3.92 with decent upside volume flows. This stock has been uptrending over the last month and change, with shares moving higher from its low of $3.15 to its recent high of $4.19 a share. During that uptrend, shares of Catalyst Pharmaceuticals have been making mostly higher lows and higher highs, which is bullish technical price action. That uptrend is also coming after this stock gapped down huge in April from around $4.80 to its low of $2.71 with massive downside volume. This spike to the upside on Thursday is now starting to push this stock within range of triggering a major breakout trade. That trade will hit if Catalyst Pharmaceuticals manages to take out some key near-term overhead resistance at $4.19 with high volume.

If you liked this article you might like

Celladon (CLDN) Stock Popping on Eiger Merger

Spark Tries to Quell Investor Fears About Gene Therapy Test

5 Stocks With Ominous Insider Selling as Market Took Painful Turn

Ride 'Shotgun' to Avoid Investing Mistakes

Ride 'Shotgun' to Avoid Investing Mistakes

10 Worst Biotech Stocks in the NASDAQ